RPRX
Royalty Pharma Plc
$26.4
Earnings Summary
Revenue | $564.69Mn |
Net Profits | $543.99Mn |
Net Profit Margins | 96.33% |
Highlights
Royalty Pharma Plc’s revenue jumped 5.29% since last year same period to $564.69Mn in the Q3 2024. On a quarterly growth basis, Royalty Pharma Plc has generated 5.1% jump in its revenue since last 3-months.
Royalty Pharma Plc’s net profit jumped 654.34% since last year same period to $543.99Mn in the Q3 2024. On a quarterly growth basis, Royalty Pharma Plc has generated 433.3% jump in its net profits since last 3-months.
Royalty Pharma Plc’s net profit margin jumped 616.44% since last year same period to 96.33% in the Q3 2024. On a quarterly growth basis, Royalty Pharma Plc has generated 407.4% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Royalty Pharma Plc post its latest quarter earnings
EPS Estimate Current Quarter | 0.93 |
EPS Estimate Current Year | 0.93 |
Highlights
Royalty Pharma Plc’s earning per share (EPS) estimates for the current quarter stand at 0.93 - a -4.12% fall from last quarter’s estimates.
Royalty Pharma Plc’s earning per share (EPS) estimates for the current year stand at 0.93.
Key Ratios
Key ratios of the Royalty Pharma Plc post its Q3 2024 earnings
Earning Per Share (EPS) | 1.01 |
Dividend Per Share (DPS) | 0.21 |
Highlights
Royalty Pharma Plc’s earning per share (EPS) jumped 27.85% since last year same period to 1.01 in the Q3 2024. This indicates that the Royalty Pharma Plc has generated 27.85% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Royalty Pharma Plc declared 0.21 dividend per share during the earnings announcement for Q3 2024.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-11-06 | 0.93 | 1.01 | 8.6% |
2024-05-09 | 0.98 | 0.98 | 0% |
2024-08-08 | 0.97 | 0.96 | -1.03% |
₹0 US Stocks a/c Opening Fee